The FDA has approved the subcutaneous formulation of nivolumab (Opdivo). This approval makes it the first and only subcutaneously administered PD-1 inhibitor. Subcutaneous nivolumab is approved in all ...
The FDA has is­sued a com­plete re­sponse let­ter to John­son & John­son for the sub­cu­ta­neous ver­sion of its lung can­cer drug Ry­bre­vant af­ter is­sues were … ...
Attention was paid to protecting the subcutaneous blood ... Doppler color ultrasound, CT imaging, etc., and initially suggested a giant mesial tissue tumor of the armpit; we performed complete ...
A lipoma is a lump under the skin that occurs due to an overgrowth of fat cells. Lipomas are typically harmless but people may wish to remove one that causes pain, complications, or other symptoms ...